CMNDClearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 1.31 $ -0.01 (-0.78 %)    

Wednesday, 15-May-2024 12:21:21 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 1.28
$ 1.29
$ 0.00 x 0
$ 0.00 x 0
$ 1.29 - $ 1.31
$ 0.92 - $ 20.40
73,529
na
777,391
$ -0.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 clearmind-medicine-advances-meai-based-alcohol-substitute-beverage-program

The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023

 why-clearmind-medicine-stock-is-moving-higher

Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yis...

Core News & Articles
Market-Moving News for May 7th
05/07/2024 12:36:21

CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with ...

 clearmind-applies-to-cease-being-a-reporting-issuer-in-canada

Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) ("Clearmind" or the "Company"), a clinical- stage biot...

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

 why-taysha-gene-therapies-shares-are-trading-higher-by-around-27-here-are-20-stocks-moving-premarket

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a y...

 clearmind-medicines-psychedelic-treatment-bags-divisional-patent-approval-in-china

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION